# Capricor Therapeutics Inc. (CAPR) fundamentals

Data as of 2026-11-04. NASDAQ, United States. Sector: Healthcare / Biotechnology. Price $8.24, market value $479 million.

## Valuation
- **P/E (trailing): n/a** (negative earnings). Capricor Therapeutics Inc. reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **Price / book: 1.9×**. The shares trade at 1.9× book value; book value is a meaningful part of the valuation.
- **Free-cash-flow yield: -24.0%** (5-yr avg -11.6%). Free cash flow is negative: the business is consuming cash, which is normal for heavy investment phases but a warning otherwise.

## Profitability
- **Return on equity: -34.4%**. Return on equity is negative because earnings are negative.
- **Return on assets: -29.5%**. Each dollar of assets produces -29.5% of profit.

## Growth
- **Revenue growth (1 yr): -100.0%** (3-yr -100.0%/yr, 5-yr -100.0%/yr). Revenue fell 100.0% over the last year, against -100.0% a year compounded over five years: growth is accelerating.
- **EPS growth (1 yr): -96.5%**. Earnings per share fell 96.5%, roughly in step with revenue.

## Financial health
- **Interest coverage: -35.5×**. Operating profit covers interest only -35.5×: fragile.
- **Current ratio: 9.01** (quick 9.01). Current assets cover the next year's liabilities 9.01 times.
- **Altman Z-score: 6.90**. A Z-score of 6.90 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 2/9**. 2 of 9 checks pass: weak or deteriorating financials.

## Dividends
- **Dividend: none**. Capricor Therapeutics Inc. does not currently pay a dividend.

## Price and momentum
- **Total return (1 yr): 11.2%** (YTD -74.9%, 3-mo 72.4%). The shares are up 11.2% over twelve months including dividends.
- **From 52-week high: -79.6%** (178.4% above the low). Trading 80% below its 52-week high, deep in a drawdown.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 51**. An RSI of 51 is neutral.
- **Beta (1 yr): 0.93** (volatility 393%). Beta of 0.93 against the S&P 500: the shares move roughly with the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=CAPR · Page: https://foliofundamentals.com/stocks/capr

Not investment advice.